Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
BACKGROUND: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to impreci...
المؤلفون الرئيسيون: | Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
BioMed Central
2011
|
مواد مشابهة
-
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
حسب: Lindegardh Niklas, وآخرون
منشور في: (2011-07-01) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
حسب: Jamsen, K, وآخرون
منشور في: (2012) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
حسب: Jamsen Kris M, وآخرون
منشور في: (2012-07-01) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
حسب: Tarning, J, وآخرون
منشور في: (2012) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
حسب: Tarning, J, وآخرون
منشور في: (2012)